Non-malignant late effects in lymphoma patients treated with autologous hematopoietic stem cell transplantation

Creative Commons License

Sirmatel P., Yilmaz H., GÜNDÜZ E.

EUROPEAN JOURNAL OF THERAPEUTICS, cilt.23, sa.3, ss.106-110, 2017 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.5152/eurjther.2017.66
  • Dergi Adı: EUROPEAN JOURNAL OF THERAPEUTICS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.106-110
  • Anahtar Kelimeler: Lymphoma, autologous hematopoietic stem cell transplantation, non-malignant, late effect, BONE-MARROW-TRANSPLANTATION, HIGH-DOSE CHEMOTHERAPY, COMPLICATIONS, CHILDHOOD, SURVIVORS, HODGKIN, ADULTS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Developments in transplantation procedures have led to an increase in the number of long-term survivors after hematopoietic stem cell transplantation (HSCT). In this study, we investigated non-malignant late side effects after autologous HSCT (AHSCT) in lymphoma patients.